Our Sponsors and Exhbitors

American Outcomes Management (AOM)
American Outcomes Management (AOM) is a nation-wide healthcare provider, committed to offering high quality, personalized home infusion services since 1994.  AOM has expertise in the treatment and administration of Intravenous Immune Globulin (IVIG) throughout the United States.  Our goal is to work with patients, families, physicians and case managers to coordinate and deliver the most cost-effective in-home care with specialized IVIG fertility infusion nurses.

Cook Medical Reproductive Health
Cook Medical Reproductive Health provides physicians with a comprehensive offering of medical devices for the reproductive system. Cook Medical is committed to education, research, and collaboration with physicians to enhance patient care for women and men throughout their reproductive lives, from diagnosis to post-delivery. For more information, please visit www.cookmedical.com/rh

EMD Serono
EMD Serono, the North America biopharmaceutical business of the science and technology leader, Merck KGaA, Darmstadt, Germany, offers therapies and patient support services for specialty conditions, like multiple sclerosis (MS), infertility, HIV Associated Wasting and growth disorders.

Esco Medical
Esco Medical is a leading manufacturer and innovator of high-quality equipment such as long-term embryo incubators, ART workstations, Anti-Vibration Table, Time-Lapse incubators and is continuously developing advanced technologies to meet the increasing demand of the IVF industry. Most products are designed in Denmark and manufactured in the EU. Esco Medical is a business unit of the Esco Group, being a global life sciences tools provider in containment, clean air, pharmaceutical, and laboratory equipment technologies with active sales in over 100 countries and direct company offices in the top ten geographical markets. 

Ferring Pharmaceuticals

Ferring Pharmaceuticals Inc. is a research‚Äźdriven biopharmaceutical company devoted to identifying, developing and marketing innovative products in the fields of reproductive health, women’s health, obstetrics, osteoarthritis,  gastroenterology and urology. To view all of our US offerings, please visit www.ferringusa.com.

Fertility Nutraceuticals, LLC
Fertility Nutraceuticals, LLC (FNC) is a specialty provider of high-quality nutritional supplements exclusively for female and male fertility.  Fertility Nutracueticals' mission is to help men and women build families through a range of unique fertility supplements, unmatched in quality, purity and consistency.  Established to address a real need for high-quality but affordable DHEA supplement for women with diminished ovarian reserve undergoing IVF, Fertility Nutraceuticals develops the highest-quality fertility supplements through incorporation of latest scientific knowledge and close collaboration with leading fertility experts.

Galen US
Galen US is based in Audubon, PA and markets SYNERA®, a topical anesthetic patch that is a technology advancement, for preventing needle-stick pain in patients. Galen works with healthcare professionals and patients to create real long-term value.

Hamilton Thorne
Hamilton Thorne is a leading world-wide provider of precision instruments, consumables, software and services that reduce cost, increase productivity, improve results and enable breakthroughs in Assisted Reproductive Technologies (ART) and developmental biology research markets. Hamilton Thorne's laser products attach to standard inverted microscopes and operate as micro-surgical devices, enabling a wide array of scientific applications and In Vitro Fertilization (IVF) procedures. Its image analysis systems are designed to bring quality, efficiency and reliability to studies of reproductive cells in the human fertility, animal sciences and reproductive toxicology fields. Hamilton Thorne’s standardized toxicology assays and quality control testing services help to improve outcomes in human IVF clinics. 

The Journal of Assisted Reproduction and Genetics publishes novel cellular, molecular, genetic, and epigenetic findings that advance our understanding of the biology of human gametes and preimplantation embryos, the origins of diseases affecting fertility, and practice of assisted reproductive technology (ARTs). The goal is to optimize and facilitate the translation of discoveries made from human or relevant animal model experimentation to the safe and efficacious practice of human assisted reproductive technologies within a scientifically rigorous and ethically sound set of standards established by the editorial leadership of JARG. The expertise, sensitivity, and commitment of the editorial board guides the marriage of contemporary research paradigms with basic science discovery in the form of original papers, mini reviews, case reports, and opinion pieces often combined into special topic issues that will educate and guide clinicians and scientists with interests in the biology of human gametes and embryos, treatment of infertility, and technological innovations in human ARTs. The guiding principles of male and female reproductive health that impact the pre- and post-conceptional viability and developmental capacity of human gametes and preimplantation embryos is emphasized within the purview of human reproductive health in current and future generations of our species.

This Springer journal is published in cooperation with the American Society for Reproductive Medicine, an organization of more than 8,000 physicians, researchers, nurses, technicians and other professionals dedicated to advancing knowledge and expertise in reproductive biology.

LifeGlobal Group
global® – Based on Pure Science and clinically proven for more than 15 years with more than 180 published independent studies.
global® Family of ART Media – Leading and clinically proven ‘Uninterrupted Culture Medium™’
LifeGlobal® media products have a proven record of consistency, quality and performance. High quality oils: LifeGuard® Oil- specially designed for uninterrupted culture; LiteOil® and LG Paraffin Oil.
LifeGlobal® GPS® Dishware – The future of ART Dishware. Specific dish design for each culture and procedure. Universal GPS®, embryo GPS®, embryo Corral®, μDrop GPS® ,
4 Well GPS® Dish and NEW: Mini GPS
LifeGlobal® Tools: New Precision µPipets™ for IVF
CodaAir®: AldaSorb® Xtra Inline® Filters, CodaAir® 800 & 900, Coda Positive Pressure Unit
Our products are manufactured in North America under strict Quality Control in our ISO 13485:2003 and ISO 9001:2008 Certified and FDA Registered facilities. Our products are FDA 510(k) Cleared, Health Canada Registered, and CE marked. www.LifeGlobalGroup.com; www.IVFonline.com. Contact Information: sales@LifeGlobal.com 24/7 Online Orders
Intl: 001 519 826-5800, NA:1-800-720-6375

Metro Drugs
Metro Drugs is a full service fertility pharmacy with over 25 years of experience with fertility patients and caregivers.  We treat every patient as if they were part of our own family.  On call 24/7 with nurses and pharmacists, we always make sure you get the right medication on time at the lowest possible price.

Nanosonics is the inventor and manufacturer of trophon EPR - the first automated HLD system that delivers fast, safe and effective ultrasound transducer disinfection. The only proven system to kill high-risk, cancer-causing HPV. To find out more: visit www.trophon.com or meet us at Nanosonics booth no. 8.

Seattle Sperm Bank
Seattle Sperm Bank is one of the world’s leading sperm banks. We have a global reach to clinics and patients throughout North America, South America, Europe, Australia, Africa and Asia. We pride ourselves on providing great donors, superior vial quality, affordable pricing and outstanding customer service. We use industry-leading screening processes and extended genetic testing. Our distributors are located worldwide, including Denmark (EU), the UK, Australia, Argentina, Brazil, South Africa, Mexico, Canada and Israel.

What's My Fertility
| Generation Medical Associates
What's My Fertility is an online screening program for young women at risk of losing their fertility prematurely.  Three physicians at the Center for Human Reproduction (CHR) in New York City, one of the world's leading clinical fertility and research centers, developed What's My Fertility, after seeing an ever-increasing number of women come to their fertility center at advanced stages of premature ovarian aging (POA) when pregnancy is difficult even with treatment.  What's My Fertility works to make POA risk screening a routine part of women's health so no woman has to suffer through the disappointment of infertility due to POA, a treatable condition if caught early.